{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:18:38Z","timestamp":1793146718100,"version":"4.5.0"},"reference-count":33,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi260534-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Few studies have evaluated whether modifiable aspects of red blood cell (RBC) transfusions are associated with recipient outcomes in very-low-birth-weight (VLBW) infants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260534-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine whether blood donor, RBC modifications and storage, or transfusion thresholds and characteristics are associated with serious adverse outcomes in VLBW infants undergoing transfusion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260534-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>Transfusion in Preterm Infants was a prospective birth cohort study that recruited VLBW infants (&amp;amp;lt;1500 g at birth) between April 1, 2019, and December 31, 2023, at 5 university-affiliated and 3 community birth hospitals in the US. Electronic medical record data linking blood donor and component data to infants were obtained and linked with Vermont Oxford Network outcome data, with additional outcome review by site. The analysis was completed in January 2026.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260534-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>RBC transfusion and transfusion characteristics, evaluated up to the first outcome event.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260534-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was a composite outcome of severe intraventricular hemorrhage (IVH), necrotizing enterocolitis (NEC), late-onset sepsis, severe bronchopulmonary dysplasia (BPD), retinopathy of prematurity, or death (and secondary individual outcomes), with follow-up through 90 days or death. Blood donor characteristics (sex, age, and hemoglobin), anticoagulant preservative solution and\/or unit characteristics, transfused volumes, transfusion number, and infants\u2019 pretransfusion hemoglobin values were evaluated using multivariable generalized estimating equation regression models to account for correlation within hospital, adjusted for illness severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260534-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The study enrolled 2605 VLBW infants, and 1283 (586 [45.7%] female; 713 [55.6%]\u2009&amp;amp;lt;27 weeks\u2019 gestational age) received RBC transfusion. Median pretransfusion hemoglobin level was associated with higher odds of the composite outcome (odds ratio [OR] per 1 g\/dL increase, 1.15; 95% CI, 1.07-1.25;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001). In contrast, use of additive solution (AS)\u20131 or AS-5 vs the reference of citrate phosphate dextrose adenine or citrate phosphate dextrose as the anticoagulant preservative solution was associated with lower odds of the composite outcome (OR, 0.72; 95% CI, 0.53-0.97;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.03). There were no significant associations with other examined modifiable factors and the composite outcome. Among secondary outcomes, anticoagulant preservative solution was associated with lower risk of BPD (AS-1 and AS-5, OR, 0.48; 95% CI, 0.33-0.69; AS-3, OR, 0.65; 95% CI, 0.56-0.77) and higher risk of NEC (AS-3, hazard ratio [HR], 5.33; 95% CI, 1.22-23.29). Transfusion dose was associated with higher risk of mortality (HR per 5 mL\/kg, 1.25; 95% CI, 1.17-1.35), and donor age was associated with a lower risk of mortality (HR for age \u226560 years, 0.63; 95% CI, 0.44-0.92). Shorter postirradiation storage duration (&amp;amp;lt;1 day) was associated with lower risk of NEC (HR, 0.44; 95% CI, 0.22-0.89). Female donor sex was associated with lower risk of IVH (HR, 0.60; 95% CI, 0.36-0.99).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260534-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this cohort study of VLBW infants, pretransfusion hemoglobin and anticoagulant preservative solution were associated with a composite of morbidities and mortality, unlike other modifiable blood banking practices. For individual outcomes, select donor and blood banking factors were identified that may be modifiable targets for further evaluation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.19301","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T15:32:21Z","timestamp":1782315141000},"page":"e2619301","source":"Crossref","is-referenced-by-count":1,"title":["Red Blood Cell Transfusion Characteristics and Morbidity or Mortality in Very-Low-Birth-Weight Infants"],"prefix":"10.1001","volume":"9","author":[{"given":"Jeanne E.","family":"Hendrickson","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Center for Transfusion and Cellular Therapies, Emory University School of Medicine, Atlanta, Georgia"},{"name":"Department of Laboratory Medicine, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J.","family":"Birch","sequence":"additional","affiliation":[{"name":"Westat, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A. K.","family":"Rowley","sequence":"additional","affiliation":[{"name":"Westat, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Sola-Visner","sequence":"additional","affiliation":[{"name":"Boston Children\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian R.","family":"Branchford","sequence":"additional","affiliation":[{"name":"Versiti Blood Research Institute, Milwaukee, Wisconsin"},{"name":"Medical College of Wisconsin, Milwaukee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuxin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Columbia University Irving Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Custer","sequence":"additional","affiliation":[{"name":"Vitalant Research Institute, San Francisco, California"},{"name":"Department of Laboratory Medicine, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"DeSimone","sequence":"additional","affiliation":[{"name":"Department of Pathology, Weill Cornell Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel W.","family":"Bougie","sequence":"additional","affiliation":[{"name":"Thrombosis and Hemostasis Program, Versiti Blood Research Institute, Milwaukee, Wisconsin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika M.","family":"Edwards","sequence":"additional","affiliation":[{"name":"Vermont Oxford Network, Burlington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchika","family":"Goel","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Simmons Cancer Institute, Southern Illinois University School of Medicine, Springfield"},{"name":"Corporate Medical Affairs, Vitalant, Scottsdale, Arizona"},{"name":"Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Gottschall","sequence":"additional","affiliation":[{"name":"Versiti Blood Research Institute, Milwaukee, Wisconsin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eldad A.","family":"Hod","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morvarid","family":"Moayeri","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nareg H.","family":"Roubinian","sequence":"additional","affiliation":[{"name":"Vitalant Research Institute, San Francisco, California"},{"name":"Department of Laboratory Medicine, University of California, San Francisco"},{"name":"Kaiser Permanente Northern California Division of Research, Pleasanton"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Karam","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Pediatric Critical Care Medicine, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.","family":"VanWormer","sequence":"additional","affiliation":[{"name":"Marshfield Clinic Research Institute, Marshfield, Wisconsin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth F.","family":"Stone","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi L. C.","family":"Luban","sequence":"additional","affiliation":[{"name":"Children\u2019s National Research Institute, Washington, DC"},{"name":"Department of Pediatrics and Pathology, George Washington University School of Medicine and Health Sciences, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra D.","family":"Josephson","sequence":"additional","affiliation":[{"name":"Cancer and Blood Disorders Institute, Johns Hopkins All Children\u2019s Hospital, St Petersburg, Florida"},{"name":"Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland"},{"name":"Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland"},{"name":"Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi M.","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Emory University School of Medicine and Children\u2019s Healthcare of Atlanta, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"NHLBI Recipient Epidemiology Donor Evaluation Study\u2013IV\u2013Pediatric (REDS-IV-P)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan E.","family":"Mast","sequence":"additional","affiliation":[{"name":"for the NHLBI Recipient Epidemiology Donor Evaluation Study\u2013IV\u2013Pediatric (REDS-IV-P)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Baumann Kreuziger","sequence":"additional","affiliation":[{"name":"for the NHLBI Recipient Epidemiology Donor Evaluation Study\u2013IV\u2013Pediatric (REDS-IV-P)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliott P.","family":"Vichinsky","sequence":"additional","affiliation":[{"name":"for the NHLBI Recipient Epidemiology Donor Evaluation Study\u2013IV\u2013Pediatric (REDS-IV-P)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan R.","family":"Spencer","sequence":"additional","affiliation":[{"name":"for the NHLBI Recipient Epidemiology Donor Evaluation Study\u2013IV\u2013Pediatric (REDS-IV-P)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce S.","family":"Sachais","sequence":"additional","affiliation":[{"name":"for the NHLBI Recipient Epidemiology Donor Evaluation Study\u2013IV\u2013Pediatric (REDS-IV-P)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Chapman","sequence":"additional","affiliation":[{"name":"for the NHLBI Recipient Epidemiology Donor Evaluation Study\u2013IV\u2013Pediatric (REDS-IV-P)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Norris","sequence":"additional","affiliation":[{"name":"for the NHLBI Recipient Epidemiology Donor Evaluation Study\u2013IV\u2013Pediatric (REDS-IV-P)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mars","family":"Stone","sequence":"additional","affiliation":[{"name":"for the NHLBI Recipient Epidemiology Donor Evaluation Study\u2013IV\u2013Pediatric (REDS-IV-P)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Ness","sequence":"additional","affiliation":[{"name":"for the NHLBI Recipient Epidemiology Donor Evaluation Study\u2013IV\u2013Pediatric (REDS-IV-P)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve H.","family":"Kleinman","sequence":"additional","affiliation":[{"name":"for the NHLBI Recipient Epidemiology Donor Evaluation Study\u2013IV\u2013Pediatric (REDS-IV-P)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"issue":"3","key":"zoi260534r1","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.pedneo.2016.03.009","article-title":"Red blood cell transfusion and clinical outcomes in extremely low birth weight preterm infants.","volume":"58","author":"Wang","year":"2017","journal-title":"Pediatr Neonatol"},{"issue":"1","key":"zoi260534r2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1055\/s-0036-1584300","article-title":"Effects of red blood cell transfusions on the risk of developing complications or death: an observational study of a cohort of very low birth weight infants.","volume":"34","author":"Ghirardello","year":"2017","journal-title":"Am J Perinatol"},{"issue":"12","key":"zoi260534r3","doi-asserted-by":"publisher","DOI":"10.1002\/14651858","article-title":"Low versus high haemoglobin concentration threshold for blood transfusion for preventing morbidity and mortality in very low birthweight infants.","volume":"12","author":"Andersen","year":"2025","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"zoi260534r4","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1001\/jama.2020.10690","article-title":"Effects of liberal vs restrictive transfusion thresholds on survival and neurocognitive outcomes in extremely low-birth-weight infants: the ETTNO randomized clinical trial.","volume":"324","author":"Franz","year":"2020","journal-title":"JAMA"},{"issue":"27","key":"zoi260534r5","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1056\/NEJMoa2020248","article-title":"Higher or lower hemoglobin transfusion thresholds for preterm infants.","volume":"383","author":"Kirpalani","year":"2020","journal-title":"N Engl J Med"},{"issue":"9","key":"zoi260534r6","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1111\/trf.17507","article-title":"How do we build a comprehensive vein-to-vein (V2V) database for conduct of observational studies in transfusion medicine? demonstrated with the Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric V2V database protocol.","volume":"63","author":"Birch","year":"2023","journal-title":"Transfusion"},{"issue":"3","key":"zoi260534r7","doi-asserted-by":"publisher","first-page":"182","DOI":"10.21037\/tp.2019.07.01","article-title":"Vermont Oxford Network: a worldwide learning community.","volume":"8","author":"Edwards","year":"2019","journal-title":"Transl Pediatr"},{"issue":"6","key":"zoi260534r8","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1159\/000479977","article-title":"ISBT 128 standard for coding medical products of human origin.","volume":"44","author":"Ashford","year":"2017","journal-title":"Transfus Med Hemother"},{"issue":"5","key":"zoi260534r9","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1111\/trf.16869","article-title":"The Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P): a research program striving to improve blood donor safety and optimize transfusion outcomes across the lifespan.","volume":"62","author":"Josephson","year":"2022","journal-title":"Transfusion"},{"issue":"4","key":"zoi260534r10","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1136\/archdischild-2019-317501","article-title":"Core outcomes in neonatology: development of a core outcome set for neonatal research.","volume":"105","author":"Webbe","year":"2020","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"zoi260534r11","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.1542\/peds.2012-1427h","article-title":"Methods of mortality risk adjustment in the NICU: a 20-year review.","volume":"131","author":"Patrick","year":"2013","journal-title":"Pediatrics"},{"issue":"6","key":"zoi260534r12","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1111\/trf.12975","article-title":"Routine storage of red blood cell (RBC) units in additive solution-3: a comprehensive investigation of the RBC metabolome.","volume":"55","author":"D\u2019Alessandro","year":"2015","journal-title":"Transfusion"},{"issue":"2","key":"zoi260534r13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.tmrv.2014.01.003","article-title":"Metabolomics of ADSOL (AS-1) red blood cell storage.","volume":"28","author":"Roback","year":"2014","journal-title":"Transfus Med Rev"},{"issue":"6","key":"zoi260534r14","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2024.104011","article-title":"It\u2019s in your blood: the impact of age, sex, genetic factors and exposures on stored red blood cell metabolism.","volume":"63","author":"D\u2019Alessandro","year":"2024","journal-title":"Transfus Apher Sci"},{"issue":"3","key":"zoi260534r15","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/trf.12884","article-title":"Metabolomics profile comparisons of irradiated and nonirradiated stored donor red blood cells.","volume":"55","author":"Patel","year":"2015","journal-title":"Transfusion"},{"issue":"2","key":"zoi260534r16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1423-0410.1990.tb02068.x","article-title":"Studies in red blood cell preservation. 2. Comparison of vesicle formation, morphology, and membrane lipids during storage in AS-1 and CPDA-1.","volume":"58","author":"Greenwalt","year":"1990","journal-title":"Vox Sang"},{"issue":"5","key":"zoi260534r18","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/vox.12911","article-title":"Red-blood-cell manufacturing methods and storage solutions differentially induce pulmonary cell activation.","volume":"115","author":"Wirtz","year":"2020","journal-title":"Vox Sang"},{"issue":"1","key":"zoi260534r19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011484.pub2","article-title":"Washed versus unwashed red blood cells for transfusion for the prevention of morbidity and mortality in preterm infants.","volume":"2016","author":"Keir","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"zoi260534r20","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.23942","article-title":"Association of blood donor sex and age with outcomes in very low-birth-weight infants receiving blood transfusion.","volume":"4","author":"Patel","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"8","key":"zoi260534r21","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1111\/trf.17471","article-title":"Quality assessment of red blood cell concentrates from blood donors at the extremes of the age spectrum: the BEST collaborative study.","volume":"63","author":"Cloutier","year":"2023","journal-title":"Transfusion"},{"issue":"4","key":"zoi260534r22","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/vox.12369","article-title":"Influence of early irradiation on in vitro red blood cell (RBC) storage variables of leucoreduced RBCs in additive solution SAG-M.","volume":"110","author":"Hauck-Dlimi","year":"2016","journal-title":"Vox Sang"},{"issue":"5","key":"zoi260534r23","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/vox.12518","article-title":"Early ?-irradiation and subsequent storage of red cells in SAG-M additive solution potentiate energy imbalance, microvesiculation and susceptibility to stress-induced apoptotic cell death.","volume":"112","author":"Qadri","year":"2017","journal-title":"Vox Sang"},{"issue":"1","key":"zoi260534r24","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s12887-018-1241-5","article-title":"Does red blood cell irradiation and\/or anemia trigger intestinal injury in premature infants with birth weight?=?1250 g? an observational birth cohort study.","volume":"18","author":"Marin","year":"2018","journal-title":"BMC Pediatr"},{"issue":"9","key":"zoi260534r25","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1111\/trf.14764","article-title":"Storage after gamma irradiation affects in vivo oxygen delivery capacity of transfused red blood cells in preterm infants.","volume":"58","author":"Saito-Benz","year":"2018","journal-title":"Transfusion"},{"issue":"5","key":"zoi260534r26","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2022.0152","article-title":"Effects of freshly irradiated vs irradiated and stored red blood cell transfusion on cerebral oxygenation in preterm infants: a randomized clinical trial.","volume":"176","author":"Saito-Benz","year":"2022","journal-title":"JAMA Pediatr"},{"issue":"4","key":"zoi260534r27","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.clp.2023.08.001","article-title":"Blood donor sex and outcomes in transfused infants.","volume":"50","author":"Salem","year":"2023","journal-title":"Clin Perinatol"},{"issue":"7","key":"zoi260534r28","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1111\/trf.17417","article-title":"Associations between blood donor sex and age, and outcomes of transfused newborn infants.","volume":"63","author":"Bahr","year":"2023","journal-title":"Transfusion"},{"key":"zoi260534r29","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jpeds.2018.04.023","article-title":"Impact of blood donor sex on transfusion-related outcomes in preterm infants.","volume":"201","author":"Murphy","year":"2018","journal-title":"J Pediatr"},{"issue":"8","key":"zoi260534r30","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1111\/trf.17468","article-title":"Associations of donor, component, and recipient factors on hemoglobin increments following red blood cell transfusion in very low birth weight infants.","volume":"63","author":"DeSimone","year":"2023","journal-title":"Transfusion"},{"issue":"12","key":"zoi260534r31","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/j.jclinepi.2015.03.016","article-title":"Many multicenter trials had few events per center, requiring analysis via random-effects models or GEEs.","volume":"68","author":"Kahan","year":"2015","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"zoi260534r32","doi-asserted-by":"publisher","DOI":"10.1016\/j.semperi.2021.151538","article-title":"The center-effect on outcomes for infants born at less than 25 weeks.","volume":"46","author":"Nair","year":"2022","journal-title":"Semin Perinatol"},{"key":"zoi260534r33","doi-asserted-by":"publisher","DOI":"10.1038\/s41372-025-02470-3","article-title":"International classification of diseases codes have low positive predictive value for neonatal morbidities.","author":"Hendrickson","year":"2025","journal-title":"J Perinatol"},{"key":"zoi260534r17","unstructured":"Association for the Advancement of Blood and Biotherapies, America's Blood Centers, American Red Cross. Circular of information for the use of human blood and blood components. June 2024. Accessed April 1, 2026. https:\/\/www.fda.gov\/media\/86898\/download"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2850682\/hendrickson_2026_oi_260534_1781620490.0998.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T15:32:29Z","timestamp":1782315149000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2850682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.19301","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]}}}